Colin Begg (statistician)

Add links
From Wikipedia, the free encyclopedia
Colin B. Begg
NationalityScottish
Alma materUniversity of Glasgow
Scientific career
FieldsBiostatistics, epidemiology
InstitutionsMemorial Sloan-Kettering Cancer Center
Thesis Statistical diagnosis  (1976)
Doctoral advisorJohn Aitchison

Colin B. Begg is a Scottish biostatistician and epidemiologist. He is an attending biostatistician at the Memorial Sloan-Kettering Cancer Center in New York City.[1] He serves as editor-in-chief of the journal Clinical Trials.[2] He has conducted research on the role of BRCA genetic variants in the development of breast cancer,[3][4] as well as racial disparities in cancer survival rates in the United States.[5]

Begg was named a Fellow of the American Statistical Association in 1996.[6]

References[edit]

  1. ^ "Colin Begg". Memorial Sloan Kettering Cancer Center. Retrieved 2018-12-07.
  2. ^ "Clinical Trials". SAGE Journals. Retrieved 2018-12-07.
  3. ^ "Breast cancer genes don't have to mean cancer". New Scientist. 2008-01-09. Retrieved 2018-12-07.
  4. ^ Alpert, Bill (2002-10-21). "Scary Statistics". Barron's. Retrieved 2018-12-07.
  5. ^ "Racial Gap in Cancer Survival Is Not Biological, Study Finds". The New York Times. Reuters. 2002-04-24. ISSN 0362-4331. Retrieved 2018-12-07.
  6. ^ "ASA Fellows list". American Statistical Association. Retrieved 2021-11-03.


This article about a statistician from the United Kingdom is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Colin_Begg_(statistician)&oldid=1184313162"